{"ticker": {"uuid": "0e9482a1-a072-43fe-b3f8-2b2fc9c7d9b1", "symbol": "000078", "name": "Shenzhen Neptunus Bioengineering Co., Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Shenzhen Neptunus Bioengineering Co.,Ltd.\u2019s Net Profit Dropped 14.7% in First Three Quarters of 2023", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOdUNuUGduVXAtTjA4eFJ4MGtkSnd6R1pSbV9nTFktdEZCMUNVd3BCM1lmb0JNNi16RWdVV0pGRUQ1blN6VFN5ZTRiLTFXdlcxaGl5VkloUkUzYmcyQXo0YmI1MlpaVjVMYnZOTjBfTlU0R3llN0pyaVZvbnNMbXdmSkNoVEVON3IzZGZSeFNqeHJUYlBaeUV3SVl2TkoxUnZhWXF5enl3WkthZm95X1lBdGlqWnVqMFhweG41YTFOaFZ5b2prZGxGWFJMRENYM2JzRTdtNlRMVjBnd25oNmwzNU00OA?oc=5", "source_name": "Caixin Global", "published_at": "2023-11-10T08:00:00+00:00", "published_display": "10 Nov 2023 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Shenzhen Neptunus Bioengineering Co., Ltd. Class A (SZSE:000078)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE11akxXUk9rLThZWXZyQmFhRXByLVNxbU1yVnFyLTlfcE9YSlR0X0NOOHRtTndleVhfR3BTSUxvV0dxVTdMS2ZXb29McG52SXFtVXRTdEV0ZVZmemcxOHk0bUNDTnhlRFFiRWJF?oc=5", "source_name": "TradingView", "published_at": "2018-02-02T23:06:02+00:00", "published_display": "02 Feb 2018 23:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Shenzhen Neptunus Bioengineering Co.,Ltd.\u2019s Net Profit Dropped 14.7% in First Three Quarters of 2023", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOdUNuUGduVXAtTjA4eFJ4MGtkSnd6R1pSbV9nTFktdEZCMUNVd3BCM1lmb0JNNi16RWdVV0pGRUQ1blN6VFN5ZTRiLTFXdlcxaGl5VkloUkUzYmcyQXo0YmI1MlpaVjVMYnZOTjBfTlU0R3llN0pyaVZvbnNMbXdmSkNoVEVON3IzZGZSeFNqeHJUYlBaeUV3SVl2TkoxUnZhWXF5enl3WkthZm95X1lBdGlqWnVqMFhweG41YTFOaFZ5b2prZGxGWFJMRENYM2JzRTdtNlRMVjBnd25oNmwzNU00OA?oc=5", "source_name": "Caixin Global", "published_at": "2023-11-10T08:00:00+00:00", "published_display": "10 Nov 2023 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Shenzhen Neptunus Bioengineering Co., Ltd. Class A (SZSE:000078)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE11akxXUk9rLThZWXZyQmFhRXByLVNxbU1yVnFyLTlfcE9YSlR0X0NOOHRtTndleVhfR3BTSUxvV0dxVTdMS2ZXb29McG52SXFtVXRTdEV0ZVZmemcxOHk0bUNDTnhlRFFiRWJF?oc=5", "source_name": "TradingView", "published_at": "2018-02-02T23:06:02+00:00", "published_display": "02 Feb 2018 23:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 42, "total_relevant": 2, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 58, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 58, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.95, "latest_week": "2026-07-17", "one_week_move": 3.2, "four_week_move": 32.7, "twelve_week_move": -41.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.993523, "market_dynamics_buy_signal": false, "relative_strength": -32.892833, "fair_value_gap": -28.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 51.4618, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.2% over one week, +32.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Caixin Global", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.2% over one week, +32.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Shenzhen Neptunus Bioengineering Co.,Ltd.\u2019s Net Profit Dropped 14.7% in First Three Quarters of 2023"}], "updated_at": "2026-07-22T03:44:44.619103+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}